Quadrant Capital Group’s Insmed INSM Stock Holding History

Quadrant Capital Group’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-21	Closed	-$3.43K	–	1880
2026 Q1	$3.43K	Buy	21 +9	+75%	+$1.38K	﹤0.01%	2423
2025 Q4	$2.09K	Hold	12	–	–	﹤0.01%	2516
2025 Q3	$1.73K	Buy	+12	New	+$1.47K	﹤0.01%	2493
2025 Q2	–	Sell	-15	Closed	-$1.15K	–	1952
2025 Q1	$1.15K	Hold	15	–	–	﹤0.01%	2587
2024 Q4	$1.04K	Hold	15	–	–	﹤0.01%	2586
2024 Q3	$1.09K	Hold	15	–	–	﹤0.01%	2581
2024 Q2	$1K	Hold	15	–	–	﹤0.01%	2562
2024 Q1	$407	Hold	15	–	–	﹤0.01%	2651
2023 Q4	$465	Hold	15	–	–	﹤0.01%	2623
2023 Q3	$379	Hold	15	–	–	﹤0.01%	2607
2023 Q2	$317	Sell	15 -8	-35%	-$152	﹤0.01%	2624
2023 Q1	$393	Hold	23	–	–	﹤0.01%	2629
2022 Q4	$460	Buy	+23	New	+$445	﹤0.01%	2635
2022 Q1	–	Sell	-6	Closed	–	–	2589
2021 Q4	$0	Sell	6 -24	-80%	-$686	﹤0.01%	2601
2021 Q3	$1K	Buy	+30	New	+$787	﹤0.01%	2323
2020 Q2	–	Sell	-8	Closed	–	–	2303
2020 Q1	$0	Buy	+8	New	+$190	﹤0.01%	2181

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Quadrant Capital Group's INSM Position: Q2 2026 in Review

Quadrant Capital Group sold out of Insmed (INSM) in Q2 2026, closing a stake of 21 shares — an estimated $3.43K sold.

Quadrant Capital Group first reported a position in INSM in Q1 2020 and held it in 16 quarters. The position peaked at $3.43K in Q1 2026. 666 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Quadrant Capital Group reported no remaining Insmed position as of Q2 2026 after selling out during the quarter.
Quadrant Capital Group sold 21 Insmed shares in Q2 2026, an estimated $3.43K.
Quadrant Capital Group first reported a position in Insmed in Q1 2020 and held it in 16 quarters.
Quadrant Capital Group's Insmed position peaked at $3.43K in Q1 2026.
666 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.